BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16606767)

  • 1. Case-control study of the parkin gene in early-onset Parkinson disease.
    Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
    Marder KS; Tang MX; Mejia-Santana H; Rosado L; Louis ED; Comella CL; Colcher A; Siderowf AD; Jennings D; Nance MA; Bressman S; Scott WK; Tanner CM; Mickel SF; Andrews HF; Waters C; Fahn S; Ross BM; Cote LJ; Frucht S; Ford B; Alcalay RN; Rezak M; Novak K; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Neils GD; Verbitsky M; Kisselev S; Caccappolo E; Ottman R; Clark LN
    Arch Neurol; 2010 Jun; 67(6):731-8. PubMed ID: 20558392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R; Racette B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.
    Pankratz N; Kissell DK; Pauciulo MW; Halter CA; Rudolph A; Pfeiffer RF; Marder KS; Foroud T; Nichols WC;
    Neurology; 2009 Jul; 73(4):279-86. PubMed ID: 19636047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease.
    Bardien S; Keyser R; Yako Y; Lombard D; Carr J
    Parkinsonism Relat Disord; 2009 Feb; 15(2):116-21. PubMed ID: 18514563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
    Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin variants in North American Parkinson's disease: cases and controls.
    Lincoln SJ; Maraganore DM; Lesnick TG; Bounds R; de Andrade M; Bower JH; Hardy JA; Farrer MJ
    Mov Disord; 2003 Nov; 18(11):1306-11. PubMed ID: 14639672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
    Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller PP; Schwinger E; Bressman SB; Fahn S; Klein C
    Neurology; 2002 Apr; 58(8):1239-46. PubMed ID: 11971093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin mutations in familial and sporadic Parkinson's disease among Indians.
    Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Goyal V; Maitra A; Muthane UB; Juyal RC; Thelma BK
    Parkinsonism Relat Disord; 2006 May; 12(4):239-45. PubMed ID: 16500134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational screening of the parkin gene among South Indians with early onset Parkinson's disease.
    Madegowda RH; Kishore A; Anand A
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1588-90. PubMed ID: 16227559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
    Sun M; Latourelle JC; Wooten GF; Lew MF; Klein C; Shill HA; Golbe LI; Mark MH; Racette BA; Perlmutter JS; Parsian A; Guttman M; Nicholson G; Xu G; Wilk JB; Saint-Hilaire MH; DeStefano AL; Prakash R; Williamson S; Suchowersky O; Labelle N; Growdon JH; Singer C; Watts RL; Goldwurm S; Pezzoli G; Baker KB; Pramstaller PP; Burn DJ; Chinnery PF; Sherman S; Vieregge P; Litvan I; Gillis T; MacDonald ME; Myers RH; Gusella JF
    Arch Neurol; 2006 Jun; 63(6):826-32. PubMed ID: 16769863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls.
    Lesage S; Lohmann E; Tison F; Durif F; Dürr A; Brice A;
    J Med Genet; 2008 Jan; 45(1):43-6. PubMed ID: 17766365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.
    Peng R; Gou Y; Yuan Q; Li T; Latsoudis H; Yuan G; Luo D; Liu X; Collier DA
    Eur Neurol; 2003; 49(2):85-9. PubMed ID: 12584415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
    Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
    Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon deletions of parkin gene in patients with Parkinson disease.
    Wang T; Liang Z; Sun S; Cao X; Peng H; Liu H; Tong E
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):262-5. PubMed ID: 15315343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease.
    Poorkaj P; Nutt JG; James D; Gancher S; Bird TD; Steinbart E; Schellenberg GD; Payami H
    Am J Med Genet A; 2004 Aug; 129A(1):44-50. PubMed ID: 15266615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
    Kay DM; Moran D; Moses L; Poorkaj P; Zabetian CP; Nutt J; Factor SA; Yu CE; Montimurro JS; Keefe RG; Schellenberg GD; Payami H
    Ann Neurol; 2007 Jan; 61(1):47-54. PubMed ID: 17187375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.
    Wiley J; Lynch T; Lincoln S; Skipper L; Hulihan M; Gosal D; Bisceglio G; Kachergus J; Hardy J; Farrer MJ
    Mov Disord; 2004 Jun; 19(6):677-81. PubMed ID: 15197707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.